ECA
IDXX icon

Elevated Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Elevated Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$526 Hold
1
– – ﹤0.01% 794
2026
Q1 		$562 Hold
1
– – ﹤0.01% 779
2025
Q4 		$677 Buy
+1
New +$681 ﹤0.01% 740

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Elevated Capital Advisors's IDXX Position: Q2 2026 in Review

Elevated Capital Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 1 share worth $526. The position accounts for ﹤0.01% of the portfolio, ranked #794.

Elevated Capital Advisors first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $677 in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Elevated Capital Advisors held 1 share of Idexx Laboratories worth $526 as of Q2 2026.
  • Elevated Capital Advisors left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q2 2026, its #794 holding.
  • Elevated Capital Advisors first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Elevated Capital Advisors's Idexx Laboratories position peaked at $677 in Q4 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Elevated Capital Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.